|
ZNF93 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.476000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.318200E-01 |
| Normal-vs-Stage2 |
6.051600E-01 |
| Normal-vs-Stage3 |
2.694200E-01 |
| Normal-vs-Stage4 |
3.197200E-01 |
| Stage1-vs-Stage2 |
8.537400E-01 |
| Stage1-vs-Stage3 |
7.219600E-01 |
| Stage1-vs-Stage4 |
1.135640E-01 |
| Stage2-vs-Stage3 |
6.773200E-01 |
| Stage2-vs-Stage4 |
2.074800E-01 |
| Stage3-vs-Stage4 |
9.009600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.606400E-01 |
| Normal-vs-AfricanAmerican |
6.115400E-01 |
| Normal-vs-Asian |
8.524800E-01 |
| Caucasian-vs-AfricanAmerican |
8.092200E-01 |
| Caucasian-vs-Asian |
3.041400E-01 |
| AfricanAmerican-vs-Asian |
5.125400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.152000E-01 |
| Normal-vs-Female |
5.313000E-01 |
| Male-vs-Female |
8.459000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.581800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.114000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.262400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.898500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.063000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.352200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.361800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.646000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.611600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.764500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.403000E-01 |
| Normal-vs-Grade 2 |
6.849200E-01 |
| Normal-vs-Grade 3 |
2.134000E-01 |
| Normal-vs-Grade 4 |
6.094000E-01 |
| Grade 1-vs-Grade 2 |
9.168400E-01 |
| Grade 1-vs-Grade 3 |
7.619200E-01 |
| Grade 1-vs-Grade 4 |
4.914000E-01 |
| Grade 2-vs-Grade 3 |
2.639000E-01 |
| Grade 2-vs-Grade 4 |
4.618000E-01 |
| Grade 3-vs-Grade 4 |
2.347000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.631600E-01 |
| Normal-vs-ccB subtype |
8.036000E-01 |
| ccA subtype-vs-ccB subtype |
1.073210E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.927600E-01 |
| Normal-vs-N1 |
5.996200E-01 |
| N0-vs-N1 |
6.667200E-01 |
|
|
